Solu Therapeutics Appoints Philip Vickers, Ph.D., as President and Chief Executive Officer
September 11, 2023 07:00 AM Eastern Daylight Time BOSTON–(BUSINESS WIRE)–Solu Therapeutics, a precision-medicine company developing therapeutics to eliminate disease-driving cells, today announced the appointment of Philip J. Vickers, Ph.D., as President and Chief Executive Officer. Dr. Vickers succeeds David Donabedian, Ph.D., Co-founder and start-up CEO of Solu Therapeutics, and Executive Partner of Longwood Fund, who will continue to serve in an advisory capacity to the … Continue reading Solu Therapeutics Appoints Philip Vickers, Ph.D., as President and Chief Executive Officer